Australian MedTech Company Partners with U.S. Cannabis Company to Develop Nasally-Delivered Medicines
Columbia Care and Rhinomed Enter into Exclusive Agreement to Develop Nasally-Delivered Cannabis-Based Products Collaboration will allow Columbia Care to develop proprietary dose-metered, nasally-delivered cannabis-based medicines NEW YORK, June...